Alopecia Treatment (Hair Loss) Market Growth Outlook and Opportunities By Key Players Viviscal, Dr. Reddy’s Laboratories Ltd., Regaine, Merck & Co., Inc, Ranbaxy Laboratories Ltd

Press Release

Alopecia Treatment (Hair Loss) Market is expected to rise from its initial estimated value of USD 8.21 billion in 2018 to an estimated value of USD 12.40 billion by 2026 registering a CAGR of 5.3% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising geriatric population along with high demand for surgical hair transplant and changing lifestyle.

The industry analysis report is generated by performing high level market research analysis of key marketplace segments to identify opportunities, challenges, drivers, and market structures for clients. The analysis and estimations conducted via this alopecia treatment (hair loss)document help to get an idea about the product launches, future products, joint ventures, marketing strategy, developments, mergers and acquisitions and effect of the same on sales, marketing, promotions, revenue, import, export, and CAGR values. Being a wide-ranging market research report, it is sure to help grow business in several ways. This comprehensive alopecia treatment (hair loss)market report employs the use of latest tools and techniques for researching, analysing and collecting data and information.

Download Sample PDF Copy of Report https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-alopecia-treatment-hair-loss-market

Few of the major market competitors currently working in the alopecia treatment (hair loss) market are

Cipla,

Viviscal,

Dr. Reddy’s Laboratories Ltd.,

Regaine,

Merck & Co., Inc,

Ranbaxy Laboratories Ltd,

Phyto – Alès Groupe,

Kirkland Signature,

Vitabiotics,

Nanogen,

Key Developments in the Market:

    • In January, 2018, Concert Pharmaceuticals, Inc. announced U.S. FDA granted Fast Track designation for CTP-543, a novel, oral Janus kinase (JAK) inhibitor for the treatment of moderate-to-severe alopecia areata, disease which attacks the hair follicles, leading to hair loss.
    • In May 2018, Histogen, Inc (U.S.) announced that received approval to Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) to study its lead product in female diffuse hair loss.
  • In March 2017, Perrigo Perrigo Company PLC (U.S.) announced the launch of over-the-counter Women’s Rogaine, which helps to regrow hair on top of the scalp.

Competitive Analysis: 

The global alopecia treatment (hair loss) market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of alopecia treatment (hair loss) market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Target Audience:

Medical device companies
Hospitals and clinics
Research and consulting firms
Healthcare associations/institutes
Venture capitalists
Government agencies

Inquire Regarding This Report  https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-alopecia-treatment-hair-loss-market

Segmentation: Global Alopecia Treatment (Hair Loss) Market

  • By Disease Type
    • Androgenic Alopecia
    • Alopecia Areata
    • Ciatricial Alopecia
    • Traction Alopecia
    • Alopecia Totalis
  • By Drug Type
    • Minoxidil
    • Finasteride
    • Cyclosporine
    • Others
  • By Gender
    • Male
    • Female
  • By Route of Administration
  • Oral
    • Topical
    • Injectable
  • By Distribution Channel
    • Hospital
    • Retail Pharmacies
    • Online Pharmacies
  • By Geography
    • North America
    • South America
    • Europe
    • Asia-Pacific
    • Middle East and Africa

Market Drivers:

  • Rising geriatric population along with high demand for surgical hair transplant will boost the market
  • Changing lifestyle along with increase in stress level among working class population can fuel the growth of the market

Market Restraints:

    • High cost of alopecia treatment (hair loss) is acting as a major restraint for the market
    • Side effects/allergic reactions by treatment also acting as a major market restraint.

For More Insights Get Detailed TOC   https://www.databridgemarketresearch.com/toc/?dbmr=global-alopecia-treatment-hair-loss-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]

Leave a Reply

Your email address will not be published. Required fields are marked *